http://www.ekfdiagnostics.com/rss.aspxLatest News From EKF Diagnostics(c) 2011, EKF Diagnostics . All rights reserved.5The majority of NHS spending on diabetes is avoidable, says a report in the journal Diabetic Medicinehttp://www.ekfdiagnostics.com/news.aspx?id=5025/04/2012 00:00:00Stanbio Laboratory announced today that the sales, marketing and service functions in the United States for its popular point-of-care HemoPoint® H2 hemoglobin system has been transitioned to Alere, Inc. http://www.ekfdiagnostics.com/news.aspx?id=5125/04/2012 00:00:00EKF Diagnostics Holdings plc, announces that it has been granted a patent in the People’s Republic of China for its Hemo Control microcuvettes, branded as NXT microcuvettes.http://www.ekfdiagnostics.com/news.aspx?id=4905/04/2012 00:00:00Argutus Medical, a subsidiary of EKF Diagnostics Holdings plc, is delighted to announce that they have applied for an ISO 13485 certificationhttp://www.ekfdiagnostics.com/news.aspx?id=4829/03/2012 00:00:00EKF Diagnostics Holdings plc, the growing in-vitro diagnostics company, announces that Tony Wilks has joined the Company as Group Head of Sales. The appointment is not a main Board appointment.http://www.ekfdiagnostics.com/news.aspx?id=4720/03/2012 00:00:00Stanbio Laboratory is announcing the availability of a new β-Hydroxybutyrate LiquiColor® kit for the Beckman Coulter Synchron® CX / LX / DX clinical systems.http://www.ekfdiagnostics.com/news.aspx?id=4619/03/2012 00:00:00EKF Diagnostics Holdings plc, a growing business within the in-vitro diagnostic devices market, announces that it has been granted a patent in the US for its HemoPoint H2 cuvettes.http://www.ekfdiagnostics.com/news.aspx?id=4508/03/2012 00:00:00Stanbio Laboratory has launched a new web portal focused on the benefits and importance of testing for diabetic ketoacidosis (DKA) – a potentially dangerous condition that can affect diabetics and others with metabolic imbalances.http://www.ekfdiagnostics.com/news.aspx?id=4427/02/2012 00:00:00 EKF Diagnostics Holdings plc (AIM: EKF), a worldwide manufacturer of point of care in-vitro diagnostic devices, announces that it has been awarded a contract to supply the State of New Mexico’s Women, Infants, and Children (WIC) clinics.http://www.ekfdiagnostics.com/news.aspx?id=4306/02/2012 00:00:00It has been recommended that all patients admitted to hospital should have their blood glucose level tested regardless of a history or prior diagnosis of diabetes.http://www.ekfdiagnostics.com/news.aspx?id=4227/01/2012 00:00:00SKUP evaluation of EKF Quo-Test A1c analyserhttp://www.ekfdiagnostics.com/news.aspx?id=4023/01/2012 00:00:00Quotient Diagnostics Ltd announces that it has attained IFCC certification for the Quo -Test A1C assay system for the period 2011-2012.http://www.ekfdiagnostics.com/news.aspx?id=3909/01/2012 00:00:00EKF announces a significant Hemo Control contract win with the Hong Kong Red Cross.http://www.ekfdiagnostics.com/news.aspx?id=3715/12/2011 00:00:00EKF's new Quo-Lab HbA1c analyser had crowds queuing up at Medica 2011.http://www.ekfdiagnostics.com/news.aspx?id=3602/12/2011 00:00:00EKF announces the order of more than 3,500 of its haemoglobin testing devices.http://www.ekfdiagnostics.com/news.aspx?id=3530/11/2011 00:00:00EKF Diagnostics announces the launch of its new HbA1c measuring device Quo-Lab at Medica.http://www.ekfdiagnostics.com/news.aspx?id=3424/11/2011 00:00:00EKF increases capacity at its manufacturing base in Walton-on-Thames to meet demand.http://www.ekfdiagnostics.com/news.aspx?id=3317/10/2011 00:00:00EKF’s Quo-Test HbA1c analyser has achieved NGSP certification for 2011 and 2012http://www.ekfdiagnostics.com/news.aspx?id=3223/09/2011 00:00:00From pulsetoday.co.uk: GPs told to switch to HbA1c testing for diabetes diagnosis.http://www.ekfdiagnostics.com/news.aspx?id=3804/07/2011 00:00:00Purchase of US diagnostics manufacturer and distributor.http://www.ekfdiagnostics.com/news.aspx?id=223/05/2011 00:00:00US distributor to sell Hemo Control in US, Canada and UKhttp://www.ekfdiagnostics.com/news.aspx?id=323/05/2011 00:00:00Chinese approval for Quo-Test analyser clears path for EKFhttp://www.ekfdiagnostics.com/news.aspx?id=527/01/2011 00:00:00EKF Diagnostics Holdings announces that it has completed the disposal of the remaining rights in the Admiral sportswear brand (being the Admiral trademarks in certain European territories) and has received the cash consideration of 238,500 in that regardhttp://www.ekfdiagnostics.com/news.aspx?id=626/01/2011 00:00:00EKF Diagnostics Holdings plc announces that it has received the cash consideration of US$774,000 in relation to the sale of the rights to the Admiral sports brand in the Americas. As announced on 24 December 2010, completion of the disposal of the remaining rights in the Admiral sportswear brand (now being the Admiral trademarks in certain European territories) is expected to complete on 28 January 2011http://www.ekfdiagnostics.com/news.aspx?id=721/01/2011 00:00:00EKF Diagnostics Holdings plc announces that it has received the final cash consideration in relation to the sale of the rights to the Admiral sports brand in the UK and Ireland and in certain other territories in North Africa and the Middle Easthttp://www.ekfdiagnostics.com/news.aspx?id=814/01/2011 00:00:00EKF Diagnostics Holdings plc announces that it has entered into agreement to dispose of its remaining rights in the Admiral sportswear brand for a cash consideration of approximately £830,000. Approximately £83,000 will be paid on exchange with the balance payable on or prior to 28 January 2011http://www.ekfdiagnostics.com/news.aspx?id=924/12/2010 00:00:00